OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

NCT00130403 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: risedronate sodium

Sponsor

Sanofi

Collaborators

[object Object]